share_log

UBS Upgrades Viatris to Neutral, Raises Price Target to $12

UBS Upgrades Viatris to Neutral, Raises Price Target to $12

瑞银将Viatris上调至中性,将目标股价提高至12美元
Benzinga Real-time News ·  2022/11/10 04:56

UBS analyst Ashwani Verma upgrades Viatris (NASDAQ:VTRS) from Sell to Neutral and raises the price target from $9 to $12.

瑞银分析师Ashwani Verma将维亚特里斯(纳斯达克:VTRS)评级从卖出上调至中性,并将目标价从9美元上调至12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发